---
$id: https://graph.org.ai/products/commodity/51111873
$type: Product
source: UNSPSC
code: "51111873"
title: "Tamoxifen"
class: "51111800"
classTitle: "Hormones and antihormones"
family: "51110000"
familyTitle: "Antineoplastic agents"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Tamoxifen

**UNSPSC Code**: 51111873
**Class**: [Hormones and antihormones](Hormones and antihormones.mdx)
**Family**: [Antineoplastic agents](../Antineoplastic agents.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a selective estrogen receptor modulator and protein kinase c inhibitor, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 094ZI81Y45. European Medicines Agency schedules Tamoxifen in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10825MIG. Tamoxifen generally arises in the molecular formula C26H29NO. The term TAMOXIFEN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 27, no. 10 1973, list 13.) TAMOXIFEN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations, for tariff and trade purposes, schedule tamoxifen under HS 29221980 and SITC 51461. As of Q4 2014, TAMOXIFEN remains US FDA's Preferred Term for this commodity. Tamoxifen bears US NLM identifiers UMLS ID C0039286 and NCI Concept Code C62078. SMILES: O(C1CCC(/C(=C(\CC)C2CCCCC2)C2CCCCC2)CC1)CCN(C)C.

